Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperuricemia × Omeprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 7 Breast Neoplasms 5 Inflammation 3 Head and Neck Neoplasms 3 Barrett Esophagus 3 Zollinger-Ellison Syndrome 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Colorectal Neoplasms 2 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Stomach Ulcer 1 Solid Tumor 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Precancerous Gastric Lesions 1 Pharmacokinetics of MDV3100 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Obesity 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hyperuricemia 1

Interventions

rasburicase 8 Urate Oxidase 5 Allopurinol 2 Omeprazole 1 Naproxen 1 Febuxostat 1 Colchicine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed

196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡